VSVerena Sailer
Verena Sailer
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Verena Sailer has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Himisha Beltran
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA
17 shared publications - Juan Miguel Mosquera
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA
17 shared publications - Mark A. Rubin
Department for BioMedical Research, University of Bern, Bern, Switzerland
17 shared publications - Andrea Sboner
Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA
16 shared publications - Benjamin David Hopkins
The Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, 10021, USA
16 shared publications - Bishoy Morris Faltas
Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA
16 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 7 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 7 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine